Hogan Lovells US LLP

Hogan Lovells US LLP’s substantial life sciences and healthcare industry sector is headed by Philadelphia-based Steve Abrams, experienced in capital markets and securities regulation, and regulatory expert Lynn Mehler, in Washington DC. With significant activity on the regulatory side, the firm counts on experts such as David Fox and Jodi Scott, who support clients on FDA matters from DC and Denver, respectively. Also in DC, Randy Prebula focuses on medical devices and technology regulatory work, while Komal Karnik Nigam is experienced in the intersection of complex regulatory and scientific issues. The team also counsels on capital market transactions, such as FPOs, and supports companies’ funding by facilitating strategic transactions and equity financing, with Houston’s Andrew Strong concentrating on emerging companies. On the other hand, Baltimore-based Lauren Colton is one of the firm’s experts in product liability. The firm is also active in IP, including patent litigation, with Cullen Taylor and Anishiya Abrol in Northern Virginia and DC, respectively, focusing on licensing and commercial transactions. In 2024, the Boston team expanded with the arrival of Brian Carey from Foley Hoag LLP, adding to the firm’s regulatory and legislative expertise; similarly, New York saw the arrival of capital markets expert Rupa Briggs from Cooley LLP.